Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Health Care
  • News
  • Penny Stocks

Surrozen Pauses Early-Stage Ulcerative Colitis Study Due To Liver Associated Adverse Events

By Vandana Singh
November 16, 7:43 AM
Tucked in its Q3 earnings release on Monday afternoon, Surrozen Inc (NASDAQ:SRZN) voluntarily paused enrollment in the single ascending dose (SAD) portion…

SRZN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

OncoSec Touts Encouraging Early Data For Opdivo Combined Immunotherapy For Skin Cancer

By Vandana Singh
November 16, 7:07 AM
OncoSec Medical Incorporated (NASDAQ:ONCS) announced early clinical data from an investigator-sponsored trial of TAVO in combination with Bristol-Myers Squibb Co’s (NYSE:BMY) intravenous Opdivo…

BMY

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Successful Alzheimer’s Data Would Have Placed Roche At Two-Year Competitive Advantage

By Vandana Singh
November 15, 6:04 PM
Before the markets opened on Monday, Roche Holdings AG (OTC:RHHBY) reported disappointing topline results from the Phase III GRADUATE-1 & 2 of…

BIIB

Read More
2 minute read
  • Biotech
  • General
  • News

Evelo Biosciences Announces Publication Of Scientific Basis For SINTAX Medicines In Frontiers In Immunology

By Benzinga Newsdesk
November 15, 5:01 PM
Peer-reviewed article explains the immunology of the small intestinal axis Company to hold a virtual Science Symposium on Wednesday, November 30, 2022, at 8:00am ET CAMBRIDGE, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE)

EVLO

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

‘Statera Biopharma (Formerly Cleveland Biolabs) Has Been Granted European Patent Number Ep3206708 Titled “Methods And Compositions For The Treatment Of Radiation-related Disorders”‘ – EPO

By Benzinga Newsdesk
November 15, 4:39 PM
METHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS - European Patent Office - EP 3206708 B1 (epo.org)  

STAB

Read More
2 minute read
  • Cannabis
  • Earnings
  • FDA
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Biomind Labs: Q3 Financials & FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression

By Lara Goldstein
November 15, 4:36 PM
Next-gen psychedelics developer Biomind Labs Inc.

BMNDF

Read More
1 minute read
  • Biotech
  • Events
  • FDA
  • General
  • News

Earlier Reported, BriaCell CEO Discusses Clinical Results Of Its Breast Cancer Immunotherapy Treatment In An Audio Interview With SmallCapVoice.com

By Benzinga Newsdesk
November 15, 1:09 PM
SmallCapVoice.com Inc. ("SCV") announces the availability of a new audio interview with Dr. Bill Williams, CEO of BriaCell Therapeutics Corp.

BCTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Neoleukin Pauses Development Of NL-201, Cuts 40% Of Employee Strength

By Vandana Singh
November 15, 11:30 AM
Neoleukin Therapeutics Inc (NASDAQ:NLTX) announced discontinuing the development of NL-201 for strategic reasons. Preliminary monotherapy data from the Phase 1 study…

NLTX

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

Insulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging

By Vandana Singh
November 15, 11:26 AM
Insulet Corporation (NASDAQ:PODD) announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with…

PODD

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Arcutis Biotherapeutics Stock Surges After Successful Atopic Dermatitis Trial

By Vandana Singh
November 15, 11:14 AM
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) announced topline results from its INTEGUMENT-1 pivotal Phase 3 trial of roflumilast cream 0.15% for mild to moderate atopic dermatitis. 

ARQT

Posts pagination

Previous 1 … 627 628 629 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service